These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7024300)

  • 1. Aberrant forms of Escherichia coli in blood cultures: in vitro reproduction of an in vivo observation.
    Magnussen CR; Hruska JF
    J Clin Microbiol; 1980 Nov; 12(5):690-4. PubMed ID: 7024300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivities of strains of enteropathogenic Escherichia coli to cephalexin and other antibiotics.
    Konforti N; Halperin E
    Am J Clin Pathol; 1975 Jul; 64(1):121-6. PubMed ID: 1098437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1975 Apr; 56(2):167-71. PubMed ID: 1106751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Med Microbiol; 1975 Feb; 8(1):205-8. PubMed ID: 1092867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.
    Greenwood D
    J Antibiot (Tokyo); 1978 Jul; 31(7):697-702. PubMed ID: 357363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on bacterial colonization. The effects of beta-lactam antibiotics on the growth of Escherichia coli and Pseudomonas aeruginosa in mixed culture.
    Tsuji A
    Microbiol Immunol; 1979; 23(8):693-704. PubMed ID: 120484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility.
    Zhang SX; Parisian F; Yau Y; Fuller JD; Poutanen SM; Richardson SE
    J Clin Microbiol; 2007 Nov; 45(11):3762-3. PubMed ID: 17728468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-lactam antibiotics on bacterial cell growth rate.
    Rolinson GN
    J Gen Microbiol; 1980 Oct; 120(2):317-23. PubMed ID: 7014771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal forms of bacteria produced by antibiotics.
    Lorian V; Atkinson B
    Am J Clin Pathol; 1975 Nov; 64(5):678-88. PubMed ID: 242211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electron microscopic study of the combined action of ampicillin and cephalexin on E. coli].
    Chavdarova V; Cherepanova N; Kharizanova T; Avramova R
    Antibiotiki; 1977 Jun; 22(6):536-9. PubMed ID: 329750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct antimicrobial susceptibility testing of gram-negative bacilli in blood cultures by an electrochemical method.
    Huang AH; Wu JJ; Weng YM; Ding HC; Chang TC
    J Clin Microbiol; 1998 Oct; 36(10):2882-6. PubMed ID: 9738038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
    Greenwood D; O'Grady F
    J Infect Dis; 1973 Aug; 128(2):211-22. PubMed ID: 4579140
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of resistance to cephalosporins in ampicillin-resistant Escherichia coli.
    Medeiros AA; O'brien TF
    J Infect Dis; 1973 Oct; 128():Suppl:S335-4. PubMed ID: 4582843
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers.
    Singh KV; Reves RR; Pickering LK; Murray BE
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2047-9. PubMed ID: 2073095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subinhibitory activity of cefaclor and cephalexin (author's transl)].
    Shah PM; Staszewski S
    Infection; 1979; 7 Suppl 6():543-6. PubMed ID: 399246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological points of view on the response of enteropathogenic strains of E. coli to ampicillin, paromomycin, gentamycin, cephalothin and nalidixic acid].
    Teodorovici G; Zvorişteanu V; Oană C; Ioan E; Ivan A; Groll M; Dănăilă F; Năstase A
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(1):103-8. PubMed ID: 4895226
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1974 Jun; 55(3):245-50. PubMed ID: 4607731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1976 Jun; 57(3):303-9. PubMed ID: 182196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.